To be commercialized as Apo-TRACE, the compound is part of a family of small molecules related to cell death.

Sigma-Aldrich licensed NeuroSurvival Technologies’ marker for molecular imaging of apoptosis in vitro and in vivo in animals. Sigma-Aldrich will manufacture and market the marker under the commercial name Apo-TRACE™.

The marker is a member of a family of apoptosis-targeting small molecules that NST developed. Another molecule of the family, ApoSense-PET, is in clinical trials for imaging apoptosis in vivo in humans with PET and is not part of this agreement.

Previous articleCrystalGenomics and ProQuest Form Palkion
Next articleInvestigators Identify Blood Biomarkers for Bipolar Disorder